The global viscosupplementation market is expected to grow significantly, reaching US$ 10.16 billion by 2033 from US$ 4.66 billion in 2024 with a CAGR of 9.02% between 2025 and 2033. The primary drivers for this growth include the increasing prevalence of osteoarthritis, aging populations, and increased awareness of non-invasive joint pain treatments. Viscosupplementation, that is, the injection of hyaluronic acid into joints, is a preferred option for managing joint degeneration, which further fuels the market's expansion. Read More: https://www.renub.com/viscosupplementation-market-p.php #Viscosupplementation_Market #Viscosupplementation_Market_Trends #Viscosupplementation_Market_Size #Viscosupplementation_Market_Share